脑部放疗，上午比下午敏感许多！
T, S( Q5 \ m- _( y3 M8 I3 P: [1 i7 \$ M4 k& u3 n3 z# H
; {- J6 `2 t3 M e7 h7 I9 _7 G) J
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.- f3 L7 Z+ P7 P+ ^" G
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?4 }! z k ^' W$ H
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.$ D" r0 i: {5 C) d" N
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) J- J9 q- v. f4 s& d% H& B' S, M2 H j% n" i
Abstract+ V. l1 a* {+ m5 O0 Y% i1 N
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.: w; f4 A$ G/ {# ~+ Z# i" `
, o( Q0 z j( k8 m! s' W8 L
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
! Q0 v8 h; o) [, C1 Q, R" j- e) b2 S9 j
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)./ }0 a- n% P! O) v
( g. P) g$ P) wCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
& h2 @* w2 L' j* \4 Z& ^
* F2 a* K+ c1 x) h |
8 \$ s# K+ P& |! L& b/ ?, s. C
显身卡
